Chile - Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use
Since 2014, Chile Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use was down by 3.2% year on year. With 52.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 23 comparing other countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use. Chile is overtaken by Estonia, which was ranked number 22 at 55 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Slovakia at 49.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Netherlands topped the ranking with 131.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 3.9% compared to 2018. Spain, United Kingdom and Iceland respectively ranked number 2, 3 and 4 in this ranking. Canada witnessed the best average annual growth at +11.3% per year, while Austria recorded the worst performance at -14% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 52.80 |
| 2018 | 54.20 |
| 2017 | 52.30 |
| 2016 | 42.20 |
| 2015 | 73.90 |
How does Chile rank in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Netherlands
|
132 | 2019 | +3.9 % | +3.5 % | View data | |
| 2 |
#2
Spain
|
129 | 2019 | +2.8 % | +0.6 % | View data | |
| 22 |
#22
Estonia
|
55 | 2019 | +7.2 % | +7.2 % | View data | |
| 23 |
#23
Chile
|
53 | 2019 | -2.6 % | -3.2 % | View data | |
| 24 |
#24
Slovakia
|
49 | 2019 | +3.6 % | +1.9 % | View data | |